NCBI Taxonomy: 2838332

Streptomyces phaeochromogenes group (ncbi_taxid: 2838332)

found 31 associated metabolites at species group taxonomy rank level.

Ancestor: Streptomyces

Child Taxonomies: Streptomyces umbrinus, Streptomyces phaeochromogenes

L-Tyrosine

(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid

C9H11NO3 (181.0739)


Tyrosine (Tyr) or L-tyrosine is an alpha-amino acid. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Amino acids are organic compounds that contain amino (–NH2) and carboxyl (–COOH) functional groups, along with a side chain (R group) specific to each amino acid. L-tyrosine is one of 20 proteinogenic amino acids, i.e., the amino acids used in the biosynthesis of proteins. Tyrosine is found in all organisms ranging from bacteria to plants to animals. It is classified as a non-polar, uncharged (at physiological pH) aromatic amino acid. Tyrosine is a non-essential amino acid, meaning the body can synthesize it – usually from phenylalanine. The conversion of phenylalanine to tyrosine is catalyzed by the enzyme phenylalanine hydroxylase, a monooxygenase. This enzyme catalyzes the reaction causing the addition of a hydroxyl group to the end of the 6-carbon aromatic ring of phenylalanine, such that it becomes tyrosine. Tyrosine is found in many high-protein food products such as chicken, turkey, fish, milk, yogurt, cottage cheese, cheese, peanuts, almonds, pumpkin seeds, sesame seeds, soy products, lima beans, avocados and bananas. Tyrosine is one of the few amino acids that readily passes the blood-brain barrier. Once in the brain, it is a precursor for the neurotransmitters dopamine, norepinephrine and epinephrine, better known as adrenalin. These neurotransmitters are an important part of the bodys sympathetic nervous system, and their concentrations in the body and brain are directly dependent upon dietary tyrosine. Tyrosine is not found in large concentrations throughout the body, probably because it is rapidly metabolized. Folic acid, copper and vitamin C are cofactor nutrients of these reactions. Tyrosine is also the precursor for hormones, including thyroid hormones (diiodotyrosine), catecholestrogens and the major human pigment, melanin. Tyrosine is an important amino acid in many proteins, peptides and even enkephalins, the bodys natural pain reliever. Valine and other branched amino acids, and possibly tryptophan and phenylalanine may reduce tyrosine absorption. A number of genetic errors of tyrosine metabolism have been identified, such as hawkinsinuria and tyrosinemia I. The most common feature of these diseases is the increased amount of tyrosine in the blood, which is marked by decreased motor activity, lethargy and poor feeding. Infection and intellectual deficits may occur. Vitamin C supplements can help reverse these disease symptoms. Some adults also develop elevated tyrosine in their blood. This typically indicates a need for more vitamin C. More tyrosine is needed under stress, and tyrosine supplements prevent the stress-induced depletion of norepinephrine and can help aleviate biochemical depression. However, tyrosine may not be good for treating psychosis. Many antipsychotic medications apparently function by inhibiting tyrosine metabolism. L-Dopa, which is directly used in Parkinsons, is made from tyrosine. Tyrosine, the nutrient, can be used as an adjunct in the treatment of Parkinsons. Peripheral metabolism of tyrosine necessitates large doses of tyrosine, however, compared to L-Dopa (http://www.dcnutrition.com). In addition to its role as a precursor for neurotransmitters, tyrosine plays an important role for the function of many proteins. Within many proteins or enzymes, certain tyrosine residues can be tagged (at the hydroxyl group) with a phosphate group (phosphorylated) by specialized protein kinases. In its phosphorylated form, tyrosine is called phosphotyrosine. Tyrosine phosphorylation is considered to be one of the key steps in signal transduction and regulation of enzymatic activity. Tyrosine (or its precursor phenylalanine) is also needed to synthesize the benzoquinone structure which forms part of coenzyme Q10. L-tyrosine is an optically active form of tyrosine having L-configuration. It has a role as an EC 1.3.1.43 (arogenate dehydrogenase) inhibitor, a nutraceutical, a micronutrient and a fundamental metabolite. It is an erythrose 4-phosphate/phosphoenolpyruvate family amino acid, a proteinogenic amino acid, a tyrosine and a L-alpha-amino acid. It is functionally related to a L-tyrosinal. It is a conjugate base of a L-tyrosinium. It is a conjugate acid of a L-tyrosinate(1-). It is an enantiomer of a D-tyrosine. It is a tautomer of a L-tyrosine zwitterion. Tyrosine is a non-essential amino acid. In animals it is synthesized from [phenylalanine]. It is also the precursor of [epinephrine], thyroid hormones, and melanin. L-Tyrosine is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). L-Tyrosine is the levorotatory isomer of the aromatic amino acid tyrosine. L-tyrosine is a naturally occurring tyrosine and is synthesized in vivo from L-phenylalanine. It is considered a non-essential amino acid; however, in patients with phenylketonuria who lack phenylalanine hydroxylase and cannot convert phenylalanine into tyrosine, it is considered an essential nutrient. In vivo, tyrosine plays a role in protein synthesis and serves as a precursor for the synthesis of catecholamines, thyroxine, and melanin. Tyrosine is an essential amino acid that readily passes the blood-brain barrier. Once in the brain, it is a precursor for the neurotransmitters dopamine, norepinephrine and epinephrine, better known as adrenalin. These neurotransmitters are an important part of the bodys sympathetic nervous system, and their concentrations in the body and brain are directly dependent upon dietary tyrosine. Tyrosine is not found in large concentrations throughout the body, probably because it is rapidly metabolized. Folic acid, copper and vitamin C are cofactor nutrients of these reactions. Tyrosine is also the precursor for hormones, thyroid, catecholestrogens and the major human pigment, melanin. Tyrosine is an important amino acid in many proteins, peptides and even enkephalins, the bodys natural pain reliever. Valine and other branched amino acids, and possibly tryptophan and phenylalanine may reduce tyrosine absorption. A number of genetic errors of tyrosine metabolism occur. Most common is the increased amount of tyrosine in the blood of premature infants, which is marked by decreased motor activity, lethargy and poor feeding. Infection and intellectual deficits may occur. Vitamin C supplements reverse the disease. Some adults also develop elevated tyrosine in their blood. This indicates a need for more vitamin C. More tyrosine is needed under stress, and tyrosine supplements prevent the stress-induced depletion of norepinephrine and can cure biochemical depression. However, tyrosine may not be good for psychosis. Many antipsychotic medications apparently function by inhibiting tyrosine metabolism. L-dopa, which is directly used in Parkinsons, is made from tyrosine. Tyrosine, the nutrient, can be used as an adjunct in the treatment of Parkinsons. Peripheral metabolism of tyrosine necessitates large doses of tyrosine, however, compared to L-dopa. A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. Dietary supplement, nutrient. Flavouring ingredient. L-Tyrosine is found in many foods, some of which are blue crab, sweet rowanberry, lemon sole, and alpine sweetvetch. An optically active form of tyrosine having L-configuration. L-Tyrosine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=60-18-4 (retrieved 2024-07-01) (CAS RN: 60-18-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex. L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex.

   

Chloramphenicol

D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenylethyl)acetamide

C11H12Cl2N2O5 (322.0123)


An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01B - Amphenicols > J01BA - Amphenicols S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3070 C254 - Anti-Infective Agent > C258 - Antibiotic C784 - Protein Synthesis Inhibitor KEIO_ID C057; [MS3] KO008919 KEIO_ID C057; [MS2] KO008918 KEIO_ID C057

   

Pyrrolnitrin

Pyrrolnitrin;3-Chloro-4-(3-chloro-2-nitrophenyl)pyrrole_HCD50

C10H6Cl2N2O2 (255.9806)


A member of the class of pyrroles carrying chloro and 3-chloro-2-nitrophenyl substituents at positions 3 and 4 respectively. D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AA - Antibiotics D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Same as: D01094

   

Phaeochromycin E

Phaeochromycin E

C14H14O4 (246.0892)


   

Phaeochromycin A

Phaeochromycin A

C18H16O5 (312.0998)


   

Phaeochromycin D

Phaeochromycin D

C17H20O4 (288.1362)


   

chloramphenicol

2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide

C11H12Cl2N2O5 (322.0123)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01B - Amphenicols > J01BA - Amphenicols S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic C784 - Protein Synthesis Inhibitor CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3461; ORIGINAL_PRECURSOR_SCAN_NO 3459 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3476; ORIGINAL_PRECURSOR_SCAN_NO 3473 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3449; ORIGINAL_PRECURSOR_SCAN_NO 3445 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3469; ORIGINAL_PRECURSOR_SCAN_NO 3467 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3457; ORIGINAL_PRECURSOR_SCAN_NO 3455 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3458; ORIGINAL_PRECURSOR_SCAN_NO 3457 Origin: Microbe, Propylene glycols, Nitrobenzenes CONFIDENCE standard compound; INTERNAL_ID 2306 CONFIDENCE standard compound; INTERNAL_ID 8318 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.577 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.575 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.573 CONFIDENCE standard compound; INTERNAL_ID 4073

   

L-Tyrosine

L-Tyrosine

C9H11NO3 (181.0739)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; OUYCCCASQSFEME-QMMMGPOBSA-N_STSL_0110_L-Tyrosine_0500fmol_180506_S2_LC02_MS02_57; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex. L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex.

   

(+)-3,4-dihydro-3,8-dihydroxy-3-methylbenz(a)anthracene-1,7,12(2H)-trione

(+)-3,4-dihydro-3,8-dihydroxy-3-methylbenz(a)anthracene-1,7,12(2H)-trione

C19H14O5 (322.0841)


   

(1s,2r,11r,14r,16s,17s)-2,8,11,16,17-pentahydroxy-16-methyl-19-oxapentacyclo[12.4.1.0¹,¹⁴.0²,¹¹.0⁴,⁹]nonadeca-4,6,8,12-tetraene-3,10,18-trione

(1s,2r,11r,14r,16s,17s)-2,8,11,16,17-pentahydroxy-16-methyl-19-oxapentacyclo[12.4.1.0¹,¹⁴.0²,¹¹.0⁴,⁹]nonadeca-4,6,8,12-tetraene-3,10,18-trione

C19H16O9 (388.0794)


   

2,8,11,16,17-pentahydroxy-16-methyl-19-oxapentacyclo[12.4.1.0¹,¹⁴.0²,¹¹.0⁴,⁹]nonadeca-4,6,8,12-tetraene-3,10,18-trione

2,8,11,16,17-pentahydroxy-16-methyl-19-oxapentacyclo[12.4.1.0¹,¹⁴.0²,¹¹.0⁴,⁹]nonadeca-4,6,8,12-tetraene-3,10,18-trione

C19H16O9 (388.0794)


   

5-(4-hydroxy-2-oxopentyl)-2-propylchromen-4-one

5-(4-hydroxy-2-oxopentyl)-2-propylchromen-4-one

C17H20O4 (288.1362)


   

(1s,3r,5r,17r)-6,6,14-trihydroxy-3-methyl-4,18,19,22-tetraoxahexacyclo[15.2.2.1¹,⁷.0³,⁵.0⁸,¹⁷.0¹⁰,¹⁵]docosa-7,10,12,14,20-pentaene-9,16-dione

(1s,3r,5r,17r)-6,6,14-trihydroxy-3-methyl-4,18,19,22-tetraoxahexacyclo[15.2.2.1¹,⁷.0³,⁵.0⁸,¹⁷.0¹⁰,¹⁵]docosa-7,10,12,14,20-pentaene-9,16-dione

C19H14O9 (386.0638)


   

6-(4,7-dihydroxy-5-oxo-2-propyl-7,8-dihydro-6h-naphthalen-1-yl)-4-hydroxypyran-2-one

6-(4,7-dihydroxy-5-oxo-2-propyl-7,8-dihydro-6h-naphthalen-1-yl)-4-hydroxypyran-2-one

C18H18O6 (330.1103)


   

5-[(5-hydroxy-6-oxopyran-2-yl)methyl]-2-propylchromen-4-one

5-[(5-hydroxy-6-oxopyran-2-yl)methyl]-2-propylchromen-4-one

C18H16O5 (312.0998)


   

6-[(7r)-4,7-dihydroxy-5-oxo-2-propyl-7,8-dihydro-6h-naphthalen-1-yl]-4-hydroxypyran-2-one

6-[(7r)-4,7-dihydroxy-5-oxo-2-propyl-7,8-dihydro-6h-naphthalen-1-yl]-4-hydroxypyran-2-one

C18H18O6 (330.1103)


   

2,2-dichloro-n-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidic acid

2,2-dichloro-n-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidic acid

C11H12Cl2N2O5 (322.0123)


   

(4-oxo-2-propylchromen-5-yl)acetic acid

(4-oxo-2-propylchromen-5-yl)acetic acid

C14H14O4 (246.0892)


   

(3r,5r)-6,6,14-trihydroxy-3-methyl-4,18,19,22-tetraoxahexacyclo[15.2.2.1¹,⁷.0³,⁵.0⁸,¹⁷.0¹⁰,¹⁵]docosa-7,10,12,14,20-pentaene-9,16-dione

(3r,5r)-6,6,14-trihydroxy-3-methyl-4,18,19,22-tetraoxahexacyclo[15.2.2.1¹,⁷.0³,⁵.0⁸,¹⁷.0¹⁰,¹⁵]docosa-7,10,12,14,20-pentaene-9,16-dione

C19H14O9 (386.0638)


   

(1r,4r,13s,14s,18s)-7,13,18-trihydroxy-17-methyl-19,20-dioxapentacyclo[12.4.1.1¹,⁴.0⁴,¹³.0⁶,¹¹]icosa-6,8,10,16-tetraene-5,12,15-trione

(1r,4r,13s,14s,18s)-7,13,18-trihydroxy-17-methyl-19,20-dioxapentacyclo[12.4.1.1¹,⁴.0⁴,¹³.0⁶,¹¹]icosa-6,8,10,16-tetraene-5,12,15-trione

C19H16O8 (372.0845)


   

(1r,4r,13r,14r,18s)-7,13,18-trihydroxy-17-methyl-19,20-dioxapentacyclo[12.4.1.1¹,⁴.0⁴,¹³.0⁶,¹¹]icosa-6,8,10,16-tetraene-5,12,15-trione

(1r,4r,13r,14r,18s)-7,13,18-trihydroxy-17-methyl-19,20-dioxapentacyclo[12.4.1.1¹,⁴.0⁴,¹³.0⁶,¹¹]icosa-6,8,10,16-tetraene-5,12,15-trione

C19H16O8 (372.0845)


   

2,2-dichloro-n-[(1r,2r)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidic acid

2,2-dichloro-n-[(1r,2r)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidic acid

C11H12Cl2N2O5 (322.0123)


   

(1s,2s,3r,5r)-3-hydroxy-2-(4-methoxy-6-oxopyran-2-yl)-3-(2-oxo-2-phenylethyl)-6-oxabicyclo[3.2.1]octan-7-one

(1s,2s,3r,5r)-3-hydroxy-2-(4-methoxy-6-oxopyran-2-yl)-3-(2-oxo-2-phenylethyl)-6-oxabicyclo[3.2.1]octan-7-one

C21H20O7 (384.1209)


   

7,13,18-trihydroxy-17-methyl-19,20-dioxapentacyclo[12.4.1.1¹,⁴.0⁴,¹³.0⁶,¹¹]icosa-6,8,10,16-tetraene-5,12,15-trione

7,13,18-trihydroxy-17-methyl-19,20-dioxapentacyclo[12.4.1.1¹,⁴.0⁴,¹³.0⁶,¹¹]icosa-6,8,10,16-tetraene-5,12,15-trione

C19H16O8 (372.0845)


   

5-[(4-hydroxy-6-oxopyran-2-yl)methyl]-2-propylchromen-4-one

5-[(4-hydroxy-6-oxopyran-2-yl)methyl]-2-propylchromen-4-one

C18H16O5 (312.0998)


   

(3s,4as,12bs)-3,4a,8,12b-tetrahydroxy-3-methyl-2,4,5,6-tetrahydrotetraphene-1,7,12-trione

(3s,4as,12bs)-3,4a,8,12b-tetrahydroxy-3-methyl-2,4,5,6-tetrahydrotetraphene-1,7,12-trione

C19H18O7 (358.1052)


   

(1e,3e,5s,7r,8r,10r,11r,12s,15r,16s,18z,25s)-11-ethyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,18,20,26-hexaen-28-one

(1e,3e,5s,7r,8r,10r,11r,12s,15r,16s,18z,25s)-11-ethyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,18,20,26-hexaen-28-one

C29H38N2O4 (478.2831)


   

5-[(4s)-4-hydroxy-2-oxopentyl]-2-propylchromen-4-one

5-[(4s)-4-hydroxy-2-oxopentyl]-2-propylchromen-4-one

C17H20O4 (288.1362)


   

6,6,14-trihydroxy-3-methyl-4,18,19,22-tetraoxahexacyclo[15.2.2.1¹,⁷.0³,⁵.0⁸,¹⁷.0¹⁰,¹⁵]docosa-7,10,12,14,20-pentaene-9,16-dione

6,6,14-trihydroxy-3-methyl-4,18,19,22-tetraoxahexacyclo[15.2.2.1¹,⁷.0³,⁵.0⁸,¹⁷.0¹⁰,¹⁵]docosa-7,10,12,14,20-pentaene-9,16-dione

C19H14O9 (386.0638)


   

6-[(7s)-4,7-dihydroxy-5-oxo-2-propyl-7,8-dihydro-6h-naphthalen-1-yl]-4-hydroxypyran-2-one

6-[(7s)-4,7-dihydroxy-5-oxo-2-propyl-7,8-dihydro-6h-naphthalen-1-yl]-4-hydroxypyran-2-one

C18H18O6 (330.1103)


   

3,4a,8,12b-tetrahydroxy-3-methyl-2,4,5,6-tetrahydrotetraphene-1,7,12-trione

3,4a,8,12b-tetrahydroxy-3-methyl-2,4,5,6-tetrahydrotetraphene-1,7,12-trione

C19H18O7 (358.1052)